We are live on ! Find out more
CIP

Chartwell Investment Partners Portfolio holdings

AUM $2.91B
1-Year Est. Return 40.48%
This Fund
S&P 500
This Quarter Est. Return
+8.86%
1 Year Est. Return
+40.48%
3 Year Est. Return
+57.16%
5 Year Est. Return
+148.97%
10 Year Est. Return
+397.87%
AUM
$3.03B
AUM Growth
+$37.3M
Cap. Flow
-$165M
Cap. Flow %
-5.47%
Top 10 Hldgs %
10.89%
Holding
446
New
42
Increased
142
Reduced
204
Closed
38

Sector Composition

Rank Sector Weight
1 Financials 18.48%
2 Technology 14.71%
3 Industrials 14.65%
4 Consumer Discretionary 11.24%
5 Healthcare 9.49%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
HEES
276
DELISTED
H&E Equipment Services
HEES
$2.11M 0.07%
63,143
-30,377
-32% -$985K
FIS icon
277
Fidelity National Information Services
FIS
$22.1B
$2.08M 0.07%
14,928
-902
-6% -$121K
CLH icon
278
Clean Harbors
CLH
$16.3B
$2.07M 0.07%
+24,095
New +$1.96M
OC icon
279
Owens Corning
OC
$12.4B
$2.06M 0.07%
31,635
+39
+0.1% +$2.5K
IAA
280
DELISTED
IAA, Inc. Common Stock
IAA
$2.05M 0.07%
43,630
-31,370
-42% -$1.32M
ICE icon
281
Intercontinental Exchange
ICE
$84.4B
$2.04M 0.07%
22,043
SITE icon
282
SiteOne Landscape Supply
SITE
$4.53B
$2.03M 0.07%
22,429
-21,993
-50% -$1.87M
ABR icon
283
Arbor Realty Trust
ABR
$998M
$2.01M 0.07%
140,353
-608
-0.4% -$8.64K
CRS icon
284
Carpenter Technology
CRS
$28.4B
$2M 0.07%
40,156
-315
-0.8% -$16.2K
QDEL icon
285
QuidelOrtho
QDEL
$838M
$1.98M 0.07%
26,373
-25,860
-50% -$1.67M
EW icon
286
Edwards Lifesciences
EW
$51.7B
$1.97M 0.07%
25,332
+2,775
+12% +$217K
TREX icon
287
Trex
TREX
$5.01B
$1.93M 0.06%
42,836
-42,004
-50% -$1.85M
LH icon
288
Labcorp
LH
$25.9B
$1.92M 0.06%
13,175
+29
+0.2% +$4.19K
AMAT icon
289
Applied Materials
AMAT
$428B
$1.91M 0.06%
31,288
-5
-0% -$281
EVOP
290
DELISTED
EVO Payments, Inc. Class A Common Stock
EVOP
$1.91M 0.06%
72,248
-70,872
-50% -$1.95M
NVCR icon
291
NovoCure
NVCR
$1.91B
$1.87M 0.06%
+22,144
New +$1.79M
COO icon
292
Cooper Companies
COO
$14.5B
$1.84M 0.06%
22,872
-24
-0.1% -$1.81K
CSFL
293
DELISTED
CenterState Bank Corporation Common Stock
CSFL
$1.83M 0.06%
73,297
-86,312
-54% -$2.16M
MRVL icon
294
Marvell Technology
MRVL
$196B
$1.82M 0.06%
68,414
-115
-0.2% -$2.91K
CRL icon
295
Charles River Laboratories
CRL
$12.8B
$1.81M 0.06%
11,832
-22
-0.2% -$3.05K
ACCO icon
296
Acco Brands
ACCO
$407M
$1.78M 0.06%
190,430
+565
+0.3% +$5.35K
HSII
297
DELISTED
Heidrick & Struggles
HSII
$1.77M 0.06%
54,465
-290
-0.5% -$8.54K
CTLT
298
DELISTED
CATALENT, INC.
CTLT
$1.76M 0.06%
31,307
-30,706
-50% -$1.57M
HELE icon
299
Helen of Troy
HELE
$693M
$1.76M 0.06%
+9,766
New +$1.57M
HRC
300
DELISTED
HILL-ROM HOLDINGS, INC.
HRC
$1.76M 0.06%
15,471
+51
+0.3% +$5.37K

Similar funds

Chartwell Investment Partners's Q4 2019 Portfolio in Review

As of Q4 2019, Chartwell Investment Partners held 446 positions worth $3.03B, up 1.2% from $2.99B the previous quarter. Its ten largest holdings account for 11% of the portfolio.

Chartwell Investment Partners withdrew a net $165M in Q4 2019, closing 38 positions and reducing 204 holdings. Its most notable exit was SunTrust Banks, Inc., an estimated $12.3M position sold in full.

By sector, the portfolio is most concentrated in Financials at 18% of assets, up from 18% a quarter earlier, followed by Technology and Industrials.

Against the trend, Chartwell Investment Partners opened a new position in Moog Inc Class A worth $16.3M.

  • Chartwell Investment Partners's largest Q4 2019 buy was Moog Inc Class A: 190,804 shares worth $16.3M.
  • Chartwell Investment Partners added most to Truist Financial in Q4 2019, an estimated $13M increase.
  • Chartwell Investment Partners's biggest Q4 2019 reduction was Pfizer, cutting an estimated $18.8M.
  • Chartwell Investment Partners fully exited SunTrust Banks, Inc. in Q4 2019, selling an estimated $12.3M.
  • Chartwell Investment Partners's ten largest holdings make up 11% of its $3.03B portfolio in Q4 2019.
  • Chartwell Investment Partners opened 42 new positions and closed 38 in Q4 2019.
  • Chartwell Investment Partners's portfolio value rose 1.2% quarter-over-quarter to $3.03B.

Based on Chartwell Investment Partners's 13F filing for Q4 2019, filed 29 Jan 2020.